Navigation Links
Sangamo BioSciences Announces Presentation of Phase 1b ZFP Therapeutic Data at American Diabetes Association Meeting
Date:6/8/2008

the SB-509-401 study was safety, we also observed statistically significant and clinically relevant improvements in a number of quantitative measures of neurological health," said Edward Lanphier, Sangamo's president and CEO. "We believe that SB-509 represents a new therapeutic approach for diabetic neuropathy, designed to directly protect and possibly restore nerve function, in contrast to the current standard of care designed to address the pain associated with this condition. We are encouraged by the data so far and are swiftly moving forward to the next stage of clinical development with our ongoing Phase 2 clinical trials. We expect to have data from our double blind Phase 2 clinical trial (SB-509-601) available in the fourth quarter of this year."

About SB-509

SB-509 is an injectable formulation of a plasmid encoding a zinc finger DNA-binding protein transcription factor (ZFP TF(TM)) designed to upregulate the expression of the gene encoding vascular endothelial growth factor (VEGF-A). VEGF-A has been demonstrated to have direct neurotrophic and neuroprotective properties. In preclinical animal efficacy studies in a diabetic rat model (Diabetes, June 1, 2006; 55(6): 1847-1854), SB-509 has proven effective in protecting motor and sensory nerve function from disease-induced nerve damage.

About the SB-509 Clinical Program

Sangamo has three ongoing Phase 2 studies in diabetics with sensory/motor neuropathy:

Phase 2 study of SB-509 for mild to moderate DN (SB-509-601)

The clinical trial is a double-blind, placebo-controlled, repeat-dosing study designed to evaluate the clinical safety and clinical effects of repeat administration of SB-509 in diabetics with mild to moderate diabetic peripheral sensory motor neuropathy in the legs. The trial is being conducted at multiple sites and is fully enrolled; data is expected to be available in the fourth quarter of 2008.

Approximately 100 subjects have been enrolled into the
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Sangamo BioSciences Provides Update on Diabetic Neuropathy Clinical Programs
2. Sangamo BioSciences Announces Presentation of Data on ZFP Therapeutic for Glioblastoma at American Association for Cancer Research (AACR) Meeting
3. Sangamo BioSciences and Sigma-Aldrich Announce Publication of Study Demonstrating Zinc Finger Technology for Rapid Generation of Knock-Out Cell Lines
4. Sangamo BioSciences Reports 2007 Fourth Quarter and Year-End Financial Results
5. Sangamo BioSciences Announces Completion of Enrollment of Phase 2 Clinical Trial of ZFP Therapeutic for Diabetic Neuropathy
6. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
7. Regado Biosciences Announces Publication in Circulation of Clinical Trial Results of REG1 Anticoagulation System
8. Magellan Biosciences Companies to Feature Automated Products and New Tests for MRSA at the American Society for Microbiology Meeting, Booth 743
9. Ardea Biosciences Presents Preclinical Data on RDEA119 Demonstrating Favorable Anti-Inflammatory Profile for Potential Use in Ulcerative Colitis
10. Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594
11. Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... BioDelivery Sciences International, Inc. (NASDAQ: BDSI ) ... Mark A. Sirgo , President and Chief Executive Officer ... Jefferies 2015 Global Healthcare Conference Tuesday, June 2 ... York City , NY The presentation will ... .  For those who are not available to listen to ...
(Date:6/2/2015)... Today the Council of State and ... companies, retailers, and human and animal health stakeholders ... CSTE is committed to supporting changes that slow ... preserve the efficacy of our existing antibiotics, and ... CSTE continues to serve as a key partner ...
(Date:6/2/2015)... , June 2, 2015  ErgoNurse, the leader in bedside ... healthcare products in the United States , ... home, long-term care and skilled nursing markets. ... Thousands ... to fully take advantage of the ErgoNurse products to stop ...
Breaking Medicine Technology:BioDelivery Sciences to Present at the Jefferies 2015 Healthcare Conference - Schedule Change 2BioDelivery Sciences to Present at the Jefferies 2015 Healthcare Conference - Schedule Change 3ErgoNurse and Briggs Healthcare Positioned to Completely Eliminate the Unnecessary Cost of Healthcare-Related Back Injuries 2
... 2011 Sigma-Aldrich Corporation (Nasdaq: SIAL) ... Gallen, Switzerland.  The new Einstein Facility located in ... to approximately 50 employees. (Logo: ... Headquarters represents a critical operational milestone for the ...
... RIDGEFIELD, Conn., April 4, 2011 ... involving Pradaxa® (dabigatran etexilate mesylate) capsules, suggested that ... 150mg over warfarin (1) occurred irrespective of CHA2DS2-VASc ... atrial fibrillation (NVAF) (permanent, persistent and paroxysmal)(3).  The ...
Cached Medicine Technology:Sigma-Aldrich Opens European Headquarters in St. Gallen, Switzerland 2New Subanalyses of the RE-LY Trial Showed Pradaxa Reduced Stroke Risk in Patients With Varying CHA2DS2-VASc Scores and Types of Non-Valvular Atrial Fibrillation 2New Subanalyses of the RE-LY Trial Showed Pradaxa Reduced Stroke Risk in Patients With Varying CHA2DS2-VASc Scores and Types of Non-Valvular Atrial Fibrillation 3New Subanalyses of the RE-LY Trial Showed Pradaxa Reduced Stroke Risk in Patients With Varying CHA2DS2-VASc Scores and Types of Non-Valvular Atrial Fibrillation 4New Subanalyses of the RE-LY Trial Showed Pradaxa Reduced Stroke Risk in Patients With Varying CHA2DS2-VASc Scores and Types of Non-Valvular Atrial Fibrillation 5New Subanalyses of the RE-LY Trial Showed Pradaxa Reduced Stroke Risk in Patients With Varying CHA2DS2-VASc Scores and Types of Non-Valvular Atrial Fibrillation 6New Subanalyses of the RE-LY Trial Showed Pradaxa Reduced Stroke Risk in Patients With Varying CHA2DS2-VASc Scores and Types of Non-Valvular Atrial Fibrillation 7New Subanalyses of the RE-LY Trial Showed Pradaxa Reduced Stroke Risk in Patients With Varying CHA2DS2-VASc Scores and Types of Non-Valvular Atrial Fibrillation 8New Subanalyses of the RE-LY Trial Showed Pradaxa Reduced Stroke Risk in Patients With Varying CHA2DS2-VASc Scores and Types of Non-Valvular Atrial Fibrillation 9
(Date:6/2/2015)... MEDIA ADVISORY, June 2, 2015 ... ewallace(at)mentalhealthamerica(dot)net , Breaking News: Congressman Tim Murphy to ... MHA Annual Conference Thursday , Who: Congressman Timothy ... the Mental Health America Annual Conference attendees and ... the Helping Families in Mental Health Crisis Act. ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 Highly qualified dental ... a plan to drive prolific change in the dental tourism ... TDC Team Dental Clinic offers a full range of ... management structure for dental tourism. , Partnered with a ... is committed to advancing dentistry and has earned a reputation ...
(Date:6/2/2015)... UCLA Health and Exer have completed negotiations ... expand urgent care services in Los Angeles County. ... of California Board of Regents and the Exer Board ... to purchase a minority share of four existing Exer ... and Northridge and creates opportunity to grow and develop ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 Bitscape Infotech ... the 2015 Microsoft Worldwide Small and Midsized Cloud Solutions ... of top Microsoft partners for demonstrating excellence in innovation ... , “This comes as no surprise to us ... third year consecutively at worldwide level by Microsoft. We ...
(Date:6/2/2015)... Grenoble, France, and Dallas, TX, USA (PRWEB) June 02, ... of innovative nano and microsystems, is deploying its growth ... healthcare applications, focusing on BioMEMS: “In Yole Développement’s May ... that the BioMEMS market will grow sharply and reach ... MEMS & Sensors at Yole Développement . , ...
Breaking Medicine News(10 mins):Health News:Congressman Tim Murphy to Unveil Details of New Mental Health Legislation at MHA Annual Conference Thursday 2Health News:Team Dental Clinic Unveils Plan to Drive Change in the Dental Tourism Industry 2Health News:Team Dental Clinic Unveils Plan to Drive Change in the Dental Tourism Industry 3Health News:UCLA Health Partners With Exer - More Than Urgent Care 2Health News:Bitscape Infotech recognized as finalist for 2015 Microsoft Worldwide small & midsized cloud solutions award. 2Health News:Bitscape Infotech recognized as finalist for 2015 Microsoft Worldwide small & midsized cloud solutions award. 3Health News:Tronics Aims to Benefit from Major Growth of Sensors and Related Technologies for Healthcare Applications 2
... Aug. 26 /PRNewswire-FirstCall/ - Hard to Treat Diseases ... to U.S. Patent and Trademark Office.("USPTO") documents relating ... Company. , HTDS management has duly notified the ... Company and is providing its shareholders with certain ...
... Pa., Aug. 26 Endo Pharmaceuticals (Nasdaq: ENDP ... by its wholly-owned subsidiary, Endo Pharmaceuticals Solutions Inc., for any ... (the "Notes") of Ledgemont Royalty Sub LLC, Endo Pharmaceuticals Solutions ... is to acquire any and all Notes to reduce the ...
... , , , DETROIT, Aug. ... affordable quality health care, or is it, as the opposition and ... fails the public? , , At "town meetings" ... TV, radio, and print ads, opponents of change have been demonizing ...
... , DENVER, Aug. 26 DaVita Inc. (NYSE: ... for those diagnosed with chronic kidney disease (CKD), in conjunction with ... at the 3rd North American Chapter meeting of the International Society ... , , (Logo: http://www.newscom.com/cgi-bin/prnh/20020729/DAVITALOGO ) , ...
... , ... The Orange County Society of Plastic Surgeons (OCSPS) recently appointed ... the nation - president of the association. OCSPS helps consumers find local ... who stress safety, excellence and integrity. As president, Dr. Sundine,s duties include ...
... Study ... ... to protect an athlete,s teeth during contact sports, mouthguards are now being questioned for their ... Sports Health: A Multidisciplinary Approach found that mouthguards may increase the number and ...
Cached Medicine News:Health News:Hard To Treat Diseases (HTDS.PK) IP Rights Pink Sheets Filings 2Health News:Hard To Treat Diseases (HTDS.PK) IP Rights Pink Sheets Filings 3Health News:Hard To Treat Diseases (HTDS.PK) IP Rights Pink Sheets Filings 4Health News:Endo Pharmaceuticals Announces Cash Tender Offer for Any and All Outstanding Ledgemont PhaRMA(SM) Secured 16% Notes 2Health News:Endo Pharmaceuticals Announces Cash Tender Offer for Any and All Outstanding Ledgemont PhaRMA(SM) Secured 16% Notes 3Health News:Endo Pharmaceuticals Announces Cash Tender Offer for Any and All Outstanding Ledgemont PhaRMA(SM) Secured 16% Notes 4Health News:Endo Pharmaceuticals Announces Cash Tender Offer for Any and All Outstanding Ledgemont PhaRMA(SM) Secured 16% Notes 5Health News:Endo Pharmaceuticals Announces Cash Tender Offer for Any and All Outstanding Ledgemont PhaRMA(SM) Secured 16% Notes 6Health News:Canadians Travel to Detroit Town Meeting to Talk About Their Health Care 2Health News:DaVita to Present Three Abstracts for the International Society for Peritoneal Dialysis 2Health News:Top Newport Beach Plastic Surgeon Appointed President of Orange County Society of Plastic Surgeons 2Health News:New Study Reveals Mouthguards are Protective, but can Cause Harm 2Health News:New Study Reveals Mouthguards are Protective, but can Cause Harm 3
... Amvex offers a complete line of ... and CO 2 . They are ... calibrations to best suit your application. ... specific to the gas in use, ...
... complete line of flowmeters, available in oxygen, air, heliox ... a variety of calibrations to best suit your application. ... gas in use, the Amvex Flowmeter is a user ... with I. For Power Take-Off add PT to the ...
... of flowmeters, available in oxygen, air, heliox and CO ... of calibrations to best suit your application. With color ... use, the Amvex Flowmeter is a user friendly device., ... For Power Take-Off add PT to the end of ...
0-3.5 LPM Oxygen Flowmeter with Ohmeda male inlet...
Medicine Products: